ImageneBio, Inc. (IMA)
4.165
+0.06
(+1.59%)
USD |
NASDAQ |
Nov 05, 16:00
ImageneBio EPS Diluted (Quarterly) : -0.6298 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6298 |
| March 31, 2026 | -0.9472 |
| December 31, 2025 | -0.6178 |
| September 30, 2025 | -3.005 |
| June 30, 2025 | -4.460 |
| March 31, 2025 | -6.474 |
| December 31, 2024 | -5.583 |
| September 30, 2024 | -4.413 |
| June 30, 2024 | -3.414 |
| March 31, 2024 | -4.015 |
| December 31, 2023 | -4.892 |
| September 30, 2023 | -4.791 |
| June 30, 2023 | -5.227 |
| March 31, 2023 | -4.706 |
| Date | Value |
|---|---|
| December 31, 2022 | -4.666 |
| September 30, 2022 | -5.738 |
| June 30, 2022 | -6.800 |
| March 31, 2022 | -5.601 |
| December 31, 2021 | 0.933 |
| September 30, 2021 | -4.855 |
| June 30, 2021 | -4.244 |
| March 31, 2021 | -3.252 |
| December 31, 2020 | -8.720 |
| September 30, 2020 | -2.083 |
| June 30, 2020 | -1.686 |
| March 31, 2020 | -2.325 |
| December 31, 2019 | -1.710 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.18M |
| Total Expenses (Quarterly) | 10.18M |
| Enterprise Value | -84.70M |
| Earnings Yield | -124.8% |
| Normalized Earnings Yield | -124.85 |